Trial Profile
Study of Belatacept-Based Immunosuppressive Regimen In Unilateral Or Bilateral Hand And Forearm Transplanted Patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2016
Price :
$35
*
At a glance
- Drugs Belatacept (Primary) ; Calcineurin inhibitors; MTOR protein inhibitors; Mycophenolate mofetil; Steroids
- Indications Transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 09 Nov 2016 New trial record